OTV-UBE3A-ATS

N/A

Report date: 2025/03/18 15:32:06
NME

Base Information

Drug NameOTV-UBE3A-ATS
Drug Alias NameOTV:UBE3A-ATSOTV-UBE3A-ATS
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUbiquitin-like modifier-activating enzyme 3A-Antisense Transcript modulators
TargetsUbiquitin-like modifier-activating enzyme 3A-Antisense Transcript
Therapy Area/IndicationsAngelman Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAngelman Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A